Lipid Nanoparticles: Future of Oral Drug Delivery and their Current Trends and Regulatory Issues
- 1. Department of Pharmaceutics, Jamia Hamdard, Hamdard University-110062
- 2. Delhi Institute of Pharmaceutical Sciences and Research, Pushp Vihar, New Delhi-110017
Description
Lipid based nanoparticles have proved to be a boon to pharma research. It has offered a wide scope to fabricate drug
delivery systems for hydrophilic as well as hydrophobic drug candidates with the advantage of being biocompatible, safe
and nontoxic dosage forms with better drug loading and easy characterization parameters. Their scaling up being an easy
task, has encouraged their industrial application. The article beautifully summarizes the different types of lipid
nanoparticles, their methods of preparation, methods of characterization, regulatory aspects governing these nanoparticles,
current trends and some developed lipid nanoparticles have also been listed so as to provide readers a deep insight into the
vast scope of lipid based nanoparticles and their advantages.
Abstract (English)
Lipid based nanoparticles have proved to be a boon to pharma research. It has offered a wide scope to fabricate drug
delivery systems for hydrophilic as well as hydrophobic drug candidates with the advantage of being biocompatible, safe
and nontoxic dosage forms with better drug loading and easy characterization parameters. Their scaling up being an easy
task, has encouraged their industrial application. The article beautifully summarizes the different types of lipid
nanoparticles, their methods of preparation, methods of characterization, regulatory aspects governing these nanoparticles,
current trends and some developed lipid nanoparticles have also been listed so as to provide readers a deep insight into the
vast scope of lipid based nanoparticles and their advantages.
Files
IJCPR,Vol7,Issue1,Article1.pdf
Files
(856.4 kB)
Name | Size | Download all |
---|---|---|
md5:2452df54a8a442dd23ce7dd301142f4a
|
856.4 kB | Preview Download |
Additional details
Dates
- Accepted
-
2015-11-11